Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Medicago begins Phase I clinical trials for candidate vaccine against COVID-19
Wednesday, July 15, 2020Medicago a biopharmaceutical company headquartered in Quebec City initiated Phase I clinical trials for the plantderived candidate vaccine against COVID during which the first doses were administered to healthy human volunteers Medicago also plans t...
Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101
Tuesday, July 14, 2020Ovid Therapeutics Inc a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases and Angelini Pharma SpA hereinafter Angelini Pharma an Italian familyowned pharmaceutical company c...
Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies
Tuesday, July 14, 2020Revitope Oncology Inc a biotechnology company advancing a new class of precision cancer immunotherapies its whollyowned subsidiary Revitope Limited Revitope Limited together with Revitope Oncology Revitope and Junshi Biosciences HK SH a leading inno...
Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients
Tuesday, July 14, 2020Merus NV a clinicalstage oncology company developing innovative fulllength multispecific antibodies Biclonics and Triclonics and Caris Life Sciences a leading innovator in molecular science focused on fulfilling the promise of precision medicine ann...
Samsung Biologics signs additional development and manufacturing agreement with STCube
Monday, July 13, 2020Samsung Biologics has further expanded its partnership with STCube through an additional development and manufacturing service agreement of STM an antiPD immunooncology candidate
Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived CAR T-Cell Therapy
Saturday, July 11, 2020Fate Therapeutics Inc a clinicalstage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders announced that the US Food and Drug Administration FDA has cleared the Companys Invest...
AGC Biologics collaborates with Molecular Partners AG to develop the DARPin® anti-COVID-19 program
Saturday, July 11, 2020Leading global company specializing in contract manufacturing and development CDMO AGC Biologics has partnered with clinical stage biotechnology company Molecular Partners AG to develop a new class of proteinbased therapeutic products that are cust...
ProteinQure collaborates with AstraZeneca to develop new therapeutic peptides
Friday, July 10, 2020ProteinQure a leader in computer discovery of proteinbased drugs announces that it will collaborate with global biopharmaceutical company AstraZeneca to apply a structurebased design method to creation of therapeutic libraries in order to accelerate...
Kymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To Patients
Friday, July 10, 2020Kymera Therapeutics Inc today announced the company has entered into a multiprogram strategic collaboration with Sanofi to develop and commercialize firstinclass protein degrader therapies targeting IRAK in patients with immuneinflammatory diseases
Zymeworks Announces New Multispecific Antibody Collaboration with Merck
Thursday, July 09, 2020Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional biotherapeutics announced that it and longtime partner Merck known as MSD outside the US and Canada have signed a new license agreement granting Merck the right to dev...
